科研动态PubMed 摘要

不同持续时间以运动为基础的肺康复干预对特发性肺纤维化患者的影响:系统评价与荟萃分析。

PubMed 学科轮询 · 2026-01-01

完整摘要 · 中文译文

背景:特发性肺纤维化(IPF)是一种慢性、致死性肺部疾病,可导致进行性瘢痕形成,严重损害呼吸功能和生活质量。尽管肺康复是重要的支持性干预措施,但不同干预时长的效果仍不确定。本研究旨在评估基于运动的肺康复在IPF患者中约3个月/12周、6个月/26周和9至12个月/52周时的效果。 方法:系统检索了Cochrane Library、Web of Science、PubMed、Embase、Scopus、中国国家知识基础设施(CNKI)、万方数据、中国科技期刊数据库和CBM数据库,检索截止至2024年5月。纳入的研究评估了基于运动的肺康复对IPF患者的影响,结局指标包括六分钟步行距离(6MWD)、圣乔治呼吸问卷(SGRQ)或其IPF专用版本IPF专用圣乔治呼吸问卷(SGRQ-I)、一氧化碳弥散量占预计值百分比(DLco%)以及使用改良医学研究委员会呼吸困难量表评估的呼吸困难评分。仅纳入以英文或中文发表的研究。 结果:共分析8项研究,涉及358名参与者。对于6MWD,合并效应支持肺康复在3个月/12周(平均差[MD]=35.98 m,95%置信区间[CI]18.05-53.92)、6个月/26周(MD=36.53 m,95%CI 19.62-53.44)和9至12个月/52周(MD=50.98 m,95%CI 25.94-76.0 3)。SGRQ/SGRQ-I在6个月(MD = -8.16,95% CI -12.33至-4.00)和9至12个月(MD = -8.76,95% CI -13.06至-4.46)改善,但在3个月时改善不明显(MD = -4.08,95% CI -9.61至1.45)。DLco%仅在9至12个月时改善(MD = 7.85,95% CI 2.80-12.90)。mMRC数据仅来自1项12周研究和1项6个月研究,因此未能在任一干预持续时间类别内进行合并。最长干预持续时间敏感性分析支持6MWD和SGRQ/SGRQ-I的获益,而DLco%无统计学显著性,mMRC的最长评估敏感性分析显示存在显著异质性。 结论:基于运动的肺康复在所评估的各干预持续时间中均与运动能力改善相关。健康相关生活质量的改善在6个月和9至12个月时观察到,而肺功能与呼吸困难方面的证据仍然有限。干预持续时间分析为探索性分析,未能确立持续时间-反应关系。

完整摘要 · 英文原文

BACKGROUND: Idiopathic pulmonary fibrosis (IPF), a chronic and fatal lung disease causing progressive scarring, severely impairs respiratory function and quality of life. Although pulmonary rehabilitation is an important supportive intervention, the effects of different intervention durations remain uncertain. This study aims to evaluate the effects of exercise-based pulmonary rehabilitation at approximately 3 months/12 weeks, 6 months/26 weeks, and 9 to 12 months/52 weeks in patients with IPF. METHODS: Systematic literature searches were conducted in the Cochrane Library, Web of Science, PubMed, Embase, Scopus, China National Knowledge Infrastructure, Wanfang Data, Chinese Science and Technology Journal Database, and CBM databases up until May 2024. Included studies assessed the impact of exercise-based pulmonary rehabilitation on patients with IPF, with outcomes measuring six-minute walk distance (6MWD), St. George's Respiratory Questionnaire (SGRQ) or its IPF-specific version IPF-specific St George's Respiratory Questionnaire (SGRQ-I), percent-predicted diffusing capacity of the lung for carbon monoxide (DLco%), and dyspnea scores using the modified Medical Research Council Dyspnoea Scale. Only studies published in English or Chinese were included. RESULTS: Eight studies with 358 participants were analyzed. For 6MWD, pooled effects favored pulmonary rehabilitation at 3 months/12 weeks (mean difference [MD] = 35.98 m, 95% confidence interval [CI] 18.05-53.92), 6 months/26 weeks (MD = 36.53 m, 95% CI 19.62-53.44), and 9 to12 months/52 weeks (MD = 50.98 m, 95% CI 25.94-76.03). SGRQ/SGRQ-I improved at 6 months (MD = -8.16, 95% CI - 12.33-- 4.00) and 9 to 12 months (MD = -8.76, 95% CI - 13.06-4.46), but not clearly at 3 months (MD = -4.08, 95% CI - 9.61-1.45). DLco% improved only at 9 to12 months (MD = 7.85, 95% CI 2.80-12.90). mMRC data were available from 1 study at 12 weeks and 1 study at 6 months and were therefore not pooled within either intervention-duration category. Longest-intervention-duration sensitivity analyses supported benefits for 6MWD and SGRQ/SGRQ-I, whereas DLco% was not statistically significant and the longest-assessment sensitivity analysis for mMRC showed substantial heterogeneity. CONCLUSION: Exercise-based pulmonary rehabilitation was associated with improved exercise capacity across the assessed intervention durations. Improvements in health-related quality of life were observed at 6 and 9 to12 months, whereas evidence for lung function and dyspnea remained limited. The intervention-duration analyses were exploratory and did not establish a duration-response relationship.

English
Effects of different durations of exercise-based pulmonary rehabilitation intervention in patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界